HemaSphere (Jun 2022)

P959: CILTACABTAGENE AUTOLEUCEL IN LENALIDOMIDE-REFRACTORY PATIENTS WITH PROGRESSIVE MULTIPLE MYELOMA AFTER 1-3 PRIOR LINES OF THERAPY: CARTITUDE-2 BIOLOGICAL CORRELATIVE ANALYSES AND UPDATED CLINICAL DATA

  • J. Hillengass,
  • A. D. Cohen,
  • M. Delforge,
  • H. Einsele,
  • H. Goldschmidt,
  • K. Weisel,
  • M.-S. Raab,
  • C. Scheid,
  • J. M. Schecter,
  • K. C. De Braganca,
  • H. Varsos,
  • T.-M. Yeh,
  • P. Mistry,
  • T. Roccia,
  • C. Corsale,
  • M. Akram,
  • L. Pacaud,
  • T. Nesheiwat,
  • M. Agha,
  • Y. C. Cohen

DOI
https://doi.org/10.1097/01.HS9.0000846704.03590.a5
Journal volume & issue
Vol. 6
pp. 849 – 850

Abstract

Read online

No abstracts available.